View Older Stories View More Recent Stories
-
Yunqi Capital issues new letter to STAAR Surgical (STAA) Board
-
Broadwood Partners rallies opposition to STAAR Surgical-Alcon deal
-
Broadwood urges STAAR board to proceed with shareholder vote on Alcon deal
-
ISS joins other advisors opposing STAAR-Alcon deal
-
Stifel Reiterates Buy Rating on Alcon Inc. (ALC), Cites Market Leadership and Growth Potential
-
Broadwood Partners questions STAAR Surgical board over Alcon sale process
-
STAAR Surgical board urges shareholders to approve Alcon merger
-
Glass Lewis recommends STAAR shareholders vote against Alcon acquisition
-
Broadwood Partners challenges STAAR Surgical deal with Alcon
-
Yunqi Capital opposes STAAR Surgical merger with Alcon
-
Broadwood opposes STAAR Surgical sale at $28 after rejecting $58 offer
-
Broadwood Partners opposes STAAR Surgical sale to Alcon
-
Alcon's STAAR acquisition clears antitrust review milestone
-
Alcon Inc. (ALC) PT Lowered to $85 at Stifel
-
Broadwood opposes STAAR Surgical acquisition by Alcon
-
STAAR Surgical board recommends $28 per share Alcon merger
-
Broadwood files preliminary proxy to block STAAR Surgical sale; company responds
-
Exclusive: Shareholder revolt threatens Alcon's takeover of STAAR Surgical
-
Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF69 at Deutsche Bank
-
Alcon (ALC) Tops Q2 EPS by 4c ; Offers Guidance
-
Alcon Inc. (ALC) PT Lowered to $104.65 at Bernstein SocGen Group
-
JPMorgan Downgrades Alcon Inc. (ALC:SW) (ALC) to Neutral
-
Alcon Inc. (ALC) PT Lowered to $100 at BofA Securities
-
Alcon Inc. (ALC) PT Lowered to $88 at Wells Fargo
-
Increasing unusual option volume: FIP COTY DINO SRRK ALC AS
-
Alcon Inc. (ALC) PT Lowered to $110 at Mizuho
-
Alcon Inc. (ALC) PT Lowered to $90 at Stifel
-
Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF84.50 at Bernstein SocGen Group
-
Alcon Inc. (ALC) PT Lowered to $80 at Morgan Stanley
-
Alcon Inc. (ALC) PT Lowered to $92 at BTIG
-
Needham Reiterates Buy Rating on Alcon Inc. (ALC)
-
Alcon reports second quarter sales rise 4% to $2.6 billion, acquires STAAR Surgical
-
Alcon (ALC) call put ratio 1 call to 1.3 puts into quarter results
-
Stifel Reiterates Buy Rating on Alcon Inc. (ALC)
-
Alcon receives Health Canada approval for Unity VCS surgical system
-
Alcon (ALC) to acquire LumiThera
-
Algoma Central (ALC) and Nova Marine JV enters agreement with POML
-
Stifel Reiterates Buy Rating on Alcon Inc. (ALC)
-
UBS: limited bull-bear debate in Europe ahead of Q2
-
Alcon (ALC) announces approval of Clareon PanOptix Pro in Canada
-
UBS identifies stock winners amid structural growth tailwinds
-
Stifel Reiterates Buy Rating on Alcon Inc. (ALC)
-
Alcon Inc. (ALC:SW) (ALC) PT Lowered to CHF89 at BofA Securities
-
UBS highlights this European MedTech stock 'as a key buying opportunity'
-
Citi Reiterates Buy Rating on Alcon Inc. (ALC:SW) (ALC)
-
BTIG Reiterates Buy Rating on Alcon Inc. (ALC)
-
Alcon (ALC) Announces FDA Approval of TRYPTYR 0.003% for the Treatment of the Signs and Symptoms of Dry Eye Disease
-
BTIG Reiterates Buy Rating on Alcon Inc. (ALC)
-
Stifel Reiterates Buy Rating on Alcon Inc. (ALC)
-
Deutsche Bank Downgrades Alcon Inc. (ALC:SW) (ALC) to Hold

